关注
Péter Buglyó
Péter Buglyó
Dept. of Inorganic & Analytical Chemistry, University of Debrecen
在 science.unideb.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Aqueous Chemistry of the VanadiumIII (VIII) and the VIII−Dipicolinate Systems and a Comparison of the Effect of Three Oxidation States of Vanadium Compounds …
P Buglyó, DC Crans, EM Nagy, RL Lindo, L Yang, JJ Smee, W Jin, LH Chi, ...
Inorganic Chemistry 44 (15), 5416-5427, 2005
1772005
Interactions of oxovanadium (IV) and the quinolone family member—ciprofloxacin
I Turel, A Golobič, A Klavžar, B Pihlar, P Buglyo, E Tolis, D Rehder, ...
Journal of inorganic biochemistry 95 (2-3), 199-207, 2003
1172003
Oxidation of 2-Propanol and Cyclohexane by the Reagent “Hydrogen Peroxide− Vanadate Anion− Pyrazine-2-carboxylic Acid”: Kinetics and Mechanism
YN Kozlov, VB Romakh, A Kitaygorodskiy, P Buglyó, G Süss-Fink, ...
The Journal of Physical Chemistry A 111 (32), 7736-7752, 2007
1132007
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants
M Andrasi, P Buglyo, L Zekany, A Gaspar
Journal of pharmaceutical and biomedical analysis 44 (5), 1040-1047, 2007
1092007
Speciation and NMR relaxation studies of VO (IV) complexes with several O-donor containing ligands: oxalate, malonate, maltolate and kojate
P Buglyó, E Kiss, I Fábián, T Kiss, D Sanna, E Garribba, G Micera
Inorganica Chimica Acta 306 (2), 174-183, 2000
1092000
Oxovanadium (IV) complexes of citric and tartaric acids in aqueous solution
T Kiss, P Buglyó, D Sanna, G Micera, P Decock, D Dewaele
Inorganica chimica acta 239 (1-2), 145-153, 1995
1021995
A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds
D Sanna, P Buglyó, G Micera, E Garribba
JBIC Journal of Biological Inorganic Chemistry 15, 825-839, 2010
932010
Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn (II), Ni (II), Cu (II) and …
DM Griffith, B Szőcs, T Keogh, KY Suponitsky, E Farkas, P Buglyó, ...
Journal of Inorganic Biochemistry 105 (6), 763-769, 2011
902011
Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum
D Sanna, L Bíró, P Buglyó, G Micera, E Garribba
Journal of Inorganic Biochemistry, 2012
792012
A New Family of Insulin‐Mimetic Vanadium Complexes Derived from 5‐Carboalkoxypicolinates
J Gätjens, B Meier, T Kiss, EM Nagy, P Buglyó, H Sakurai, K Kawabe, ...
Chemistry–A European Journal 9 (20), 4924-4935, 2003
772003
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug
D Sanna, V Ugone, G Micera, P Buglyó, L Bíró, E Garribba
Dalton Transactions 46 (28), 8950-8967, 2017
742017
Vanadyl− Thiazolidinedione combination agents for diabetes therapy
T Storr, D Mitchell, P Buglyó, KH Thompson, VG Yuen, JH McNeill, ...
Bioconjugate chemistry 14 (1), 212-221, 2003
712003
The system VO2+ - oxidized glutathione: a potentiometric and spectroscopic study
J Costa Pessoa, I Tomaz, T Kiss, P Buglyo
Journal of Inorganic Biochemistry 84 (3), 259-270, 2001
702001
The systems VIVO2+-glutathione and related ligands: a potentiometric and spectroscopic study
J Pessoa, I Tomaz, T Kiss, E Kiss, P Buglyó
JBIC Journal of Biological Inorganic Chemistry 7, 225-240, 2002
652002
Biotransformation of BMOV in the presence of blood serum proteins
D Sanna, L Bíró, P Buglyó, G Micera, E Garribba
Metallomics 4 (1), 33-36, 2012
642012
VO2+ and Cu2+ complexation by ligands based on pyridine nitrogen donors
E Garribba, D Sanna, P Buglyo, I Tomaz, JC Pessoa, S Borović, G Micera
Dalton Transactions, 2012
62*2012
An iron-based molecular redox switch as a model for iron release from enterobactin via the salicylate binding mode
TR Ward, A Lutz, SP Parel, J Ensling, P Gütlich, P Buglyó, C Orvig
Inorganic chemistry 38 (22), 5007-5017, 1999
571999
Complexes of aminophosphonates—10. Copper (II) complexes of phosphonic derivatives of iminodiacetate and nitrilotriacetate
P Buglyó, T Kiss, M Dyba, M Jezowska-Bojczuk, H Kozlowski, S Bouhsina
Polyhedron 16 (19), 3447-3454, 1997
571997
Hydrolytic behaviour and chloride ion binding capability of [Ru (η 6-p-cym)(H 2 O) 3] 2+: A solution equilibrium study
L Bíró, E Farkas, P Buglyó
Dalton Transactions 41 (1), 285-291, 2012
522012
Complex formation between Ru (η 6-p-cym)(H 2 O) 3] 2+ and (O, O) donor ligands with biological relevance in aqueous solution
L Bíró, E Farkas, P Buglyó
Dalton Transactions 39 (42), 10272-10278, 2010
512010
系统目前无法执行此操作,请稍后再试。
文章 1–20